MMP-12 Deficiency and Pulmonary Fibrosis in Mice
Author Information
Author(s): Manoury Boris, Nenan Soazig, Guenon Isabelle, Boichot Elisabeth, Planquois Jean-Michel, Bertrand Claude P, Lagente Vincent
Primary Institution: INSERM U620, Université de Rennes 1, Rennes, France
Hypothesis
Does MMP-12 deficiency affect the development of bleomycin-induced pulmonary fibrosis in mice?
Conclusion
MMP-12 deficiency has no significant effect on bleomycin-induced fibrosis.
Supporting Evidence
- MMP-12 mRNA was not detected in MMP-12 -/- mice.
- Collagen content increased similarly in MMP-12 -/- and WT mice after bleomycin administration.
- TGF-β protein levels were similar in both MMP-12 -/- and WT mice.
Takeaway
The study found that mice without MMP-12 still developed lung scarring after a treatment, showing that MMP-12 isn't needed for this type of lung damage.
Methodology
Mice were treated with bleomycin and analyzed for collagen deposition and inflammatory responses.
Limitations
The study focused only on MMP-12 and did not explore other potential mediators of fibrosis.
Participant Demographics
C57BL/6 and Balb/c male mice, including MMP-12 deficient mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website